Cellebrite (CLBT) boosts H1 2026 revenue 17% while net income falls sharply - Stock Titan

Cellebrite (CLBT) boosts H1 2026 revenue 17% while net income falls sharply Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type 6-K Rhea-AI Filing Summary Cellebrite DI Ltd. reported higher revenue but lower profitability for the six months ended June 30, 2026. Total revenue rose to $259.4 million from $220.8 million, a 17% increase, driven mainly by subscription revenue of $237.3 million, up 19% year over year. Subscription services reached $194.2 million and term licenses $43.1 million. Gross profit increased to $211.8 million with an 82% gross margin, down from 84%, as cost of subscription services grew 78% due to higher hosting, support, third-party costs and amortization. Operating expenses rose 23% to $195.7 million, led by higher research and development, sales and marketing, and general and administrative spending, including greater personnel and marketing costs. Net income declined to $17.3 million from $36.9 million, and operating cash flow decreased to $37.5 million from $53.5 million. The balance sheet remains strong. Cash, cash equivalents, short‑term deposits and marketable securities totaled $545.7 million as of June 30, 2026, compared with $535.0 million at year‑end 2025, with no credit facilities outstanding. Deferred revenue and remaining performance obligations indicate substantial contracted future revenue, with $370.4 million of performance obligations outstanding. Cellebrite also completed the acquisition of SCG Canada Inc., adding drone‑forensics technology via a $23.5 million intangible asset. Positive Revenue up 17% year over year to $259.4 million for the six months ended June 30, 2026, with subscription revenue up 19% to $237.3 million, reflecting continued adoption and contribution from the Corellium acquisition. Strong liquidity position with $545.7 million in cash, cash equivalents, short‑term deposits and marketable securities as of June 30, 2026, and no credit facilities, supporting ongoing investment and operations. High gross margins maintained, with total gross margin at 82% and subscription gross margin at 87%, despite cost pressures from hosting, support and amortization. Strategic technology expansion through the acquisition of SCG Canada Inc., adding drone‑forensics capabilities via a $23.5 million acquired technology intangible asset amortized over five years. Negative Net income fell by more than half, declining from $36.9 million to $17.3 million for the six‑month period, as operating expenses and tax expense grew faster than revenue. Operating cash flow decreased from $53.5 million to $37.5 million, reflecting lower net income and a $12.9 million decrease in deferred revenue in 2026. Margin compression in core subscription business, with subscription gross margin down from 91% to 87%, driven by a 78% increase in cost of subscription services. Tax expense more than doubled from $3.2 million to $7.5 million (up 132%), mainly due to lower deductible share‑based compensation under local tax rules, reducing after‑tax profitability. Filing Explained Existing holders faced a higher share count: 250,785,933 shares were outstanding on June 30, 2026 after 2,204,891 shares were issued during the half-year. As a Form 6-K, this is an interim report from a foreign private issuer, furnishing unaudited financial statements and an operating review for the six months ended June 30, 2026. The filing is incorporated by reference into the company’s Form F-3 and Form S-8 registration statements, extending this report’s disclosure into those existing registration documents. The statement of shareholders’ equity reports 2,204,891 ordinary shares issued through option, RSU, PSU and ESPP activity; outstanding shares were 250,785,933 at June 30, 2026, versus 248,581,042 at December 31, 2025. Issuing additional shares increases the share count and reduces an existing holder’s percentage ownership absent offsetting changes. The company completed the SCG Canada acquisition on March 1, 2026 as an asset acquisition, paying $15,293 thousand at closing and recording $1,707 thousand of deferred consideration payable on March 1, 2027; the acquired technology’s gross intangible asset was $23,490 thousand. One further share-count change remains conditional: 1,500,000 Restricted Sponsor Shares were unvested at June 30, 2026, pending a $30.00 ordinary-share price target, so they were not reported as issued in this filing. For additional equity-plan overhang, the filing reports 3,856,978 options outstanding and 10,588,230 unvested RSUs and PSUs at June 30, 2026; it does not state that these awards will be issued. Key Figures Total Revenue: $259.4 million Net Income: $17.3 million Subscription Revenue: $237.3 million +5 more 8 metrics TOTAL REVENUE $259.4 million Six months ended June 30, 2026; up 17% from $220.8 million in 2025 NET INCOME $17.3 million Six months ended June 30, 2026; down from $36.9 million in 2025 SUBSCRIPTION REVENUE $237.3 million Six months ended June 30, 2026; 19% increase versus $198.8 million in 2025 GROSS MARGIN 82% Six months ended June 30, 2026; down from 84% in the prior-year period OPERATING CASH FLOW $37.5 million Net cash provided by operating activities in the first half of 2026 CASH & INVESTMENTS $545.7 million Cash, cash equivalents, short‑term deposits and marketable securities as of June 30, 2026 REMAINING PERFORMANCE OBLIGATIONS $370.4 million Transaction price allocated to remaining performance obligations as of June 30, 2026 SCG INTANGIBLE ASSET $23.5 million Gross technology intangible asset from SCG Canada Inc. acquisition, amortized over five years Key Terms Remaining performance obligations, Share-based compensation, Deferred revenue, Cash flow hedge, +2 more 6 terms Remaining Performance Obligations FINANCIAL Share-Based Compensation FINANCIAL Deferred Revenue FINANCIAL Cash Flow Hedge FINANCIAL Restricted Sponsor Shares FINANCIAL Asset Acquisition FINANCIAL Earnings Snapshot Total Revenue: $259.4 million Six months ended June 30, 2026 Total Revenue $259.4 million Increased 17% from $220.8 million in the prior-year period Net Income $17.3 million Decreased from $36.9 million in the prior-year period Subscription Revenue $237.3 million Increased 19% from $198.8 million in the prior-year period Operating Cash Flow $37.5 million Decreased from $53.5 million in the prior-year period FAQ How did Cellebrite (CLBT) revenue perform in the first half of 2026? Cellebrite generated $259.4 million in revenue for the six months ended June 30, 2026, up 17% from $220.8 million in 2025. Growth was driven mainly by subscription revenue, which increased 19% to $237.3 million. What was Cellebrite (CLBT) net income for the six months ended June 30, 2026? Net income was $17.3 million for the six months ended June 30, 2026, compared with $36.9 million a year earlier. The decline reflects higher operating expenses and a significant increase in tax expense. How strong is Cellebrite (CLBT) liquidity as of June 30, 2026? As of June 30, 2026, Cellebrite held $545.7 million in cash, cash equivalents, short‑term deposits and marketable securities. The company reports no credit facilities and expects existing resources to fund organic operations for at least the next 12 months. What are Cellebrite (CLBT) remaining performance obligations as of June 30, 2026? Remaining performance obligations totaled $370.4 million as of June 30, 2026, including $313.3 million of billed and $57.1 million of unbilled consideration. Cellebrite expects to recognize the majority as revenue within 12 months. How did Cellebrite (CLBT) operating cash flow change in the first half of 2026? Net cash provided by operating activities was $37.5 million in the first half of 2026, down from $53.5 million in 2025. Lower net income and a $12.9 million decrease in deferred revenue contributed to the decline. What acquisition did Cellebrite (CLBT) complete in early 2026? On March 1, 2026, Cellebrite acquired 100% of SCG Canada Inc., a drone‑forensics specialist. The deal created a technology intangible asset of $23.5 million, including $15.3 million cash, $1.7 million deferred consideration and related tax effects. How are Cellebrite (CLBT) operating expenses trending? Total operating expenses rose 23% to $195.7 million in the first half of 2026. Research and development increased 29%, sales and marketing 12%, and general and administrative 44%, mainly due to higher salaries, benefits and marketing activities. AI-generated analysis. How Rhea-AI works. Not financial advice. Find StockTitan more easily in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google Add on Google Not now Form 6-K: How Foreign Companies Report to the SEC → AVAILABLE ON EDGAR 08/13/2026 - 04:02 PM ACCEPTED BY SEC EDGAR 08/13/2026 - 04:01 PM Learn about SEC filing dates ⛶ Fullscreen Source: View Original Filing on SEC EDGAR Filing Exhibits & Attachments 7 documents PRESS RELEASES EX-99.1 CONSOLIDATED FINANCIAL STATEMENTS OF CELLEBRITE DI LTD. AND ITS SUBSIDIARIES FOR 496.6 KB EX-99.2 OPERATING AND FINANCIAL REVIEW AND PROSPECTS FOR THE SIX MONTHS ENDED JUNE 30, 2 119.8 KB OTHER DOCUMENTS EX-101 XBRL SCHEMA FILE 47.0 KB EX-101 XBRL CALCULATION FILE 55.6 KB EX-101 XBRL DEFINITION FILE 128.3 KB EX-101 XBRL LABEL FILE 377.9 KB EX-101 XBRL PRESENTATION FILE 278.1 KB